Advanced search
Publication Cover
Cancer Investigation Volume 21, 2003 - Issue 6
Submit an article Journal homepage
113
Views
27
CrossRef citations to date
0
Altmetric
Original Article

A Dose-Escalating Pilot Study of Sterically Stabilized, Pegylated Liposomal Doxorubicin (Lipo-Dox®) in Patients with Metastatic Breast Cancer

Ta-Chung Chao Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
, M.D.,
Wei-Shu Wang Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
,
Chueh-Chuan Yen Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
,
Tzeon-Jye Chiou Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
,
Jin-Hwang Liu Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
&
Po-Min Chen Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, No. 201, Sec. 2, Shih-Pai Rd., Taipei, 112, Taiwan ROC
, M.D., Ph.D.
Pages 837-847 | Published online: 12 Oct 2003

References

  • Hortobagyi G. N. Anthracyclines in the treatment of cancer. An overview. Drugs 1997; 54(suppl 4)1–7
  • Aapro M. S. Combining new agents with anthracyclines in metastatic breast cancer: an overview of recent findings. Semin. Oncol. 1999; 26(suppl 3)17–21
  • Tan A. R., Swain S. M. Adjuvant chemotherapy for breast cancer: an update. Semin. Oncol. 2001; 28(4)359–376
  • Allen T. M. Liposomes. Opportunities in drug delivery. Drugs 1997; 54(suppl 4)8–14
  • Gabizon A., Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumors. Drugs 1997; 54(suppl 4)15–21
  • Muggia F. M. Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers. Drugs 1997; 54(suppl 4)22–29
  • Alberts D. S., Garcia D. J. Safety aspects of pegylated liposomal doxorubicin in patients with cancer. Drugs 1997; 54(suppl 4)30–35
  • Gabizon A., Goren D., Horowitz A. T., Tzemach D., Lossos A., Siegal T. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv. Drug Deliv. Rev. 1997; 24: 337–344
  • Drummond D. C., Meyer O., Hong K., Kirpotin D. B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999; 51(4)691–743
  • Ranson M. R., Cheeseman S., White S., Margison J. Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer. Crit. Rev. Oncol. Hematol. 2001; 37: 115–120
  • Gabizon A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 2001; 19(4)424–436
  • Sparano J. A., Winer E. P. Liposomal anthracyclines for breast cancer. Semin. Oncol. 2001; 28(4)32–40, (suppl 12)
  • Ranson M. R., Carmichael J., O'Byrne K., Stewart S., Smith D., Howell A. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J. Clin. Oncol. 1997; 15(10)3185–3191
  • Hong R. L., Tseng Y. L. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors. Cancer 2001; 91(9)1826–1833
  • Gianni L. Anthracycline resistance: the problem and its current definition. Semin. Oncol. 1997; 24(4)11–17, (suppl 10)
  • Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Tsao D., Yehoshua Z., Libson E., Muggia F. M., Babizon A. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol. 1995; 13(7)1777–1785
  • Lyass O., Uziely B., Ben-Yosef R., Tzemach D., Heshing N. I., Lotem M., Brufman G., Gabizon A. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (doxil) in metastatic breast carcinoma. Cancer 2000; 89(5)1037–1047
  • Smith F. P., Barr F., Hendricks C., Burrell L. Phase II study of DOXIL (pegylated liposomal doxorubicin) in doxorubicin-resistant, metastatic breast cancer. Am. Soc. Clin. Oncol. 1999; 18, abstract 524
  • Cowens J. W., Creaven P. J., Greco W. R., Brenner D. E., Tung Y., Ostro M., Pilkiewicz R., Ginsberg R., Petrelli N. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res. 1993; 53: 2796–2802
  • Safra T., Muggia F., Jeffers S., Tsao-Wei D. D., Groshen S., Lyass O., Henderson R., Berry G., Gabizon A. Pegylated liposomal doxorubicin (DOXIL): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann. Oncol. 2000; 11: 1029–1033
  • Mustafa M. H. Decreased risk of cardiotoxicity with long-term use of doxil/caelyx at high lifetime cumulative doses in patients with AIDS-related Kaposi's sarcoma (KS). Am. Soc. Clin. Oncol. 2001; 20, abstract 2915
  • Harris L., Batist G., Belt R., Rovira D., Navari R., Azarnia N., Welles L., Winer E., for the TLC D-99 Study Group. Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast cacinoma. Cancer 2002; 94(1)25–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.